Sargramostim Pregnancy and Breastfeeding Warnings
Brand names: Leukine
Medically reviewed by Drugs.com. Last updated on Sep 9, 2024.
Sargramostim Pregnancy Warnings
This drug should be used during pregnancy only if clearly needed.
US FDA pregnancy category: C
Comments: Female patients of childbearing potential should be apprised of the potential harm to the fetus.
Animal studies have not been reported. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Sargramostim Breastfeeding Warnings
This drug should be used only if clearly needed.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
See also
References for pregnancy information
- (2001) "Product Information. Leukine (sargramostim)." Immunex Corporation
References for breastfeeding information
- (2001) "Product Information. Leukine (sargramostim)." Immunex Corporation
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.